Drew Rasco practices Hematology. He attended University of Texas Southwestern Medical School. Drew Rasco is also a published physician. He has 14 publication published. The most recent publication is: A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer. He is registered with Medicare and accepts Medicare payments.
University of Texas Southwestern Medical School
Emory University
University of Texas Medical School| NPI NUMBER | 1558311225 | |
| NPPES Provider LastName | RASCO | |
| NPPES Provider FirstName | DREW | |
| NPPES Provider ZIPCode | 782293307 | |
| NPPES Provider State | TX | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 232.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 34.0 | |
| Percent Opioid Claims | 14.66 |
| National Provider Identifier [NPI] | 1558311225 |
| Last Name Of The Provider | RASCO |
| First Name Of The Provider | DREW |
| View All |
|
Dr. Edgar A. Castillo Dandreis, MD |
|
Dr. Lindsay L. Peterson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gregory J. Guzley, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edsel L. Hesita, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Manuel A. Santiago, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sukeshi R. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Allyson L. Harroff, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Carl R. Meier, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James B. Ellis, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alexei Arkhipov, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David J. Haile, MD |
|
Dr. Frederick L. Flynt Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph My, DO |
|
Dr. Rogelio I. Gonzalez, MD |
|
Dr. Arun R. Rao, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael A. Wiggins, MD |